Doug A Medvetz, Khadijah M Hindi, Matthew J Panzner, Andrew J Ditto, Yang H Yun, Wiley J Youngs
A class of Ag(I) N-heterocyclic carbene silver complexes, 1-3, derived from 4,5-dichloro-1H-imidazole has been evaluated for their anticancer activity against the human cancer cell lines OVCAR-3 (ovarian), MB157 (breast), and Hela (cervical). Silver complexes 1-3 are active against the ovarian and breast cancer cell lines. A preliminary in vivo study shows 1 to be active against ovarian cancer in mice. The results obtained in these studies warrant further investigation of these compounds in vivo.
一类由4,5-二氯- 1h -咪唑衍生的Ag(I) n -杂环碳银配合物1-3对人卵巢癌OVCAR-3、乳腺癌MB157和宫颈癌Hela细胞的抗癌活性进行了评价。银复合物1-3对卵巢癌和乳腺癌细胞系有活性。一项初步的体内研究表明,1对小鼠卵巢癌有活性。在这些研究中获得的结果证明了这些化合物在体内的进一步研究。
{"title":"Anticancer Activity of Ag(I) N-Heterocyclic Carbene Complexes Derived from 4,5-Dichloro-1H-Imidazole.","authors":"Doug A Medvetz, Khadijah M Hindi, Matthew J Panzner, Andrew J Ditto, Yang H Yun, Wiley J Youngs","doi":"10.1155/2008/384010","DOIUrl":"https://doi.org/10.1155/2008/384010","url":null,"abstract":"<p><p>A class of Ag(I) N-heterocyclic carbene silver complexes, 1-3, derived from 4,5-dichloro-1H-imidazole has been evaluated for their anticancer activity against the human cancer cell lines OVCAR-3 (ovarian), MB157 (breast), and Hela (cervical). Silver complexes 1-3 are active against the ovarian and breast cancer cell lines. A preliminary in vivo study shows 1 to be active against ovarian cancer in mice. The results obtained in these studies warrant further investigation of these compounds in vivo.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2008 ","pages":"384010"},"PeriodicalIF":0.0,"publicationDate":"2008-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2008/384010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9743287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In medicinal chemistry field, the biochemical pathways, involved in 7-transmembrane domains G-protein coupled receptors (GPCRs) activation, are commonly studied to establish the activity of ligands towards GPCRs. The most studied steps are the measurement of activated GTP-alpha subunit and stimulated intracellular cAMP. At the present, many researchers defined agonist or antagonist activity of potential GPCRs drugs employing [(35)S]GTPgammaS or [(3)H]cAMP as probes. Recently, the corresponding lanthanide labels Eu-GTP and Eu-cAMP as alternative to radiochemicals have been developed because they are highly sensitive, easy to automate, easily synthesized, they display a much longer shelf-life and they can be used in multilabel experiments. In the present review, the receptor-drug interaction by europium employment for studying the biochemical pathway of GPCR activation has been focused. Moreover, comparative studies between lanthanide label probes and the corresponding radiolabeled compounds have been carried out.
{"title":"Receptor-drug interaction: europium employment for studying the biochemical pathway of g-protein-coupled receptor activation.","authors":"Colabufo Nicola Antonio, Perrone Maria Grazia, Contino Marialessandra, Berardi Francesco, Perrone Roberto","doi":"10.1155/2007/12635","DOIUrl":"https://doi.org/10.1155/2007/12635","url":null,"abstract":"<p><p>In medicinal chemistry field, the biochemical pathways, involved in 7-transmembrane domains G-protein coupled receptors (GPCRs) activation, are commonly studied to establish the activity of ligands towards GPCRs. The most studied steps are the measurement of activated GTP-alpha subunit and stimulated intracellular cAMP. At the present, many researchers defined agonist or antagonist activity of potential GPCRs drugs employing [(35)S]GTPgammaS or [(3)H]cAMP as probes. Recently, the corresponding lanthanide labels Eu-GTP and Eu-cAMP as alternative to radiochemicals have been developed because they are highly sensitive, easy to automate, easily synthesized, they display a much longer shelf-life and they can be used in multilabel experiments. In the present review, the receptor-drug interaction by europium employment for studying the biochemical pathway of GPCR activation has been focused. Moreover, comparative studies between lanthanide label probes and the corresponding radiolabeled compounds have been carried out.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"12635"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/12635","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27329424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G Gencheva, D Tsekova, G Gochev, G Momekov, G Tyuliev, V Skumryev, M Karaivanova, P R Bontchev
Three novel stable Pt(III) complexes with distorted octahedral structure and (dz2)1 ground state have been obtained in the course of Pt(II)-hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis-[Pt(III)(NH3)2(Hp-3H)(H2O)2]H2O1, [Pt(III)(Hp-3H)(H2O)2]H2O2, and [Pt((O,O)Hp-2H)Cl(H2O)3] 3, were studied by UV-Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis-platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW-3 cells (KE-37 derivative) is due to induction of cell death through apoptosis.
{"title":"Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents.","authors":"G Gencheva, D Tsekova, G Gochev, G Momekov, G Tyuliev, V Skumryev, M Karaivanova, P R Bontchev","doi":"10.1155/2007/67376","DOIUrl":"https://doi.org/10.1155/2007/67376","url":null,"abstract":"<p><p>Three novel stable Pt(III) complexes with distorted octahedral structure and (dz2)1 ground state have been obtained in the course of Pt(II)-hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis-[Pt(III)(NH3)2(Hp-3H)(H2O)2]H2O1, [Pt(III)(Hp-3H)(H2O)2]H2O2, and [Pt((O,O)Hp-2H)Cl(H2O)3] 3, were studied by UV-Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis-platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW-3 cells (KE-37 derivative) is due to induction of cell death through apoptosis.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"67376"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/67376","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27296153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin-3-carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal-ligand binding mode in the new Ln(III) complexes of coumarin-3-carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of CCA(-) to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K-562 cell line.
{"title":"New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.","authors":"Irena Kostova, Georgi Momekov, Peya Stancheva","doi":"10.1155/2007/15925","DOIUrl":"https://doi.org/10.1155/2007/15925","url":null,"abstract":"<p><p>New complexes of samarium(III), gadolinium(III), and dysprosium(III) with coumarin-3-carboxylic acid (HCCA) were prepared by the reaction of the ligand with respective metal nitrates in ethanol. The structures of the final complexes were determined by means of physicochemical data, elemental analysis, IR and Raman spectra. The metal-ligand binding mode in the new Ln(III) complexes of coumarin-3-carboxylic acid was elucidated. The vibrational study gave evidence for bidentate coordination of CCA(-) to Ln(III) ions through the carbonylic oxygen and the carboxylic oxygen atoms. The complexes were tested for antiproliferative activitiy on the chronic myeloid leukemia-derived K-562, overexpressing the BCR-ABL fusion protein. Cytotoxicity towards tumor cells was determined for a broad concentration range. The samarium salt exerted a very weak antiproliferative effect on these cells. This is in contrast to the lanthanide complexes, especially samarium complex, which exhibited potent antiproliferative activity. The present study confirms our previous observations that the lanthanide complexes of coumarins exhibit antiproliferative activity towards K-562 cell line.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"15925"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/15925","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27264931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kalagouda B Gudasi, Vidyadhar C Havanur, Siddappa A Patil, Basavaraj R Patil
New lanthanide(III) complexes with 2-[2-hydroxy-3-methoxyphenyl]-3-[hydroxyl-3-methoxybenzylamino]-1,2-dihydroquin- azoline-4(3H)-one (Hmpbaq) have been synthesized and characterized by elemental analysis, conductance measurements, magnetic susceptibilities, spectroscopic (IR, NMR, UV, EPR), and thermal studies. Molar conductance studies indicate 1 : 1 electrolytic behavior for these complexes. IR spectra indicate that Hmpbaq acts as a tridentate ligand coordinating through carbonyl oxygen, benzyl amine nitrogen, and deprotonated phenolic oxygen. TG and DTA studies of La(III) and Pr(III) complexes indicate the presence of two coordinated water molecules. Based on these studies, the complexes have been formulated as [La(mpbaq)(2)(H(2)O)(2)].NO(3), where Ln = La(III), Pr(III), Nd(III), Sm(III), Eu(III), Gd(III), Th(III), Dy(III), and Y(III). The ligand, lanthanide(III) salts, and the corresponding complexes have been simultaneously screened for their antibacterial and antifungal activities and compared with the drugs in use.
{"title":"Antimicrobial Study of Newly Synthesized Lanthanide(III) Complexes of 2-[2-hydroxy-3-methoxyphenyl]-3-[2-hydroxy-3-methoxybenzylamino]-1,2-dihydroquinazolin-4(3H)-one.","authors":"Kalagouda B Gudasi, Vidyadhar C Havanur, Siddappa A Patil, Basavaraj R Patil","doi":"10.1155/2007/37348","DOIUrl":"https://doi.org/10.1155/2007/37348","url":null,"abstract":"<p><p>New lanthanide(III) complexes with 2-[2-hydroxy-3-methoxyphenyl]-3-[hydroxyl-3-methoxybenzylamino]-1,2-dihydroquin- azoline-4(3H)-one (Hmpbaq) have been synthesized and characterized by elemental analysis, conductance measurements, magnetic susceptibilities, spectroscopic (IR, NMR, UV, EPR), and thermal studies. Molar conductance studies indicate 1 : 1 electrolytic behavior for these complexes. IR spectra indicate that Hmpbaq acts as a tridentate ligand coordinating through carbonyl oxygen, benzyl amine nitrogen, and deprotonated phenolic oxygen. TG and DTA studies of La(III) and Pr(III) complexes indicate the presence of two coordinated water molecules. Based on these studies, the complexes have been formulated as [La(mpbaq)(2)(H(2)O)(2)].NO(3), where Ln = La(III), Pr(III), Nd(III), Sm(III), Eu(III), Gd(III), Th(III), Dy(III), and Y(III). The ligand, lanthanide(III) salts, and the corresponding complexes have been simultaneously screened for their antibacterial and antifungal activities and compared with the drugs in use.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"37348"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/37348","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27296155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This is the first issue of Metal Based Drugs, our journal, restyled and resumed after 5 years' silence. A number of distinguished scientists have agreed to be Associate Editors and to assist in the new course of this multidisciplinary journal, to encourage it to survive and to be the forum where to post the most important findings of our intriguing research of new and innovative metal-based drugs. With your help, the journal has an excellent potential to rapidly become the most important reference in the biomedical literature of drugs for diseases such as cancer and diabetes or for diagnostics based on the modern molecular approach formetals in biology and medicine. Undoubtedly, of the many fields where metals can help medicine with innovative drugs, chemotherapy and particularly cancer chemotherapy is forever attracting considerable interest. In this context it is important to note that there is a decreasing interest in DNA-damaging drugs. Unlike the era initiated with the discovery of the anticancer activity of mechlorethamine in 1940s, it is more commonly accepted that the new golden era of cancer chemotherapy is driven by a new series of drugs characterized by their capacity to interact with targets expressed with high selectivity only by tumour cells and this is now giving rise to drugs that are actually available in clinical practice. It is clear that the “old drugs” will still accompany us in the clinical treatment of tumours for many years. It is similarly evident that the few improvements we may expect from these drugs (those acting on nucleic acids or on macromolecules of the mitotic spindle) are those associated with a better pharmacokinetic profile that can lead to the reduction of systemic toxicity, the main problem limiting the use of such drugs. Researchers are now convinced that targets such as DNA, RNA, and tubulin do not provide sufficient selectivity for cancer cells without negative effects on healthy tissues. Also, factors such as the high tendency to develop resistance towards chemotherapeutic agents, the genetic instability of tumour cells, their heterogeneity, and their elevated mutation index are elements sufficient to circumvent the practical application of chemotherapy. Furthermore, we now have new ways to develop and research ideas on the processes of gene regulation involved in tumour malignancy: activation and repression of signal transduction pathways depending on various extracellular signals and/or cellmutations that select their capacity to survive, generate tumours, and to invade and give rise to metastases, the ultimate target of chemotherapy. We therefore have important work to do: to obtain new metal-based drugs that are not related to cisplatin or platinum analogues currently in use or in the advanced stages of development, since these represent part of the old strategy of antitumour chemotherapy. We are conscious of the difficulties of the game but we will run this race with the important advantage
{"title":"Metal based drugs restyled and resumed.","authors":"Gianni Sava","doi":"10.1155/2007/16260","DOIUrl":"https://doi.org/10.1155/2007/16260","url":null,"abstract":"This is the first issue of Metal Based Drugs, our journal, restyled and resumed after 5 years' silence. A number of distinguished scientists have agreed to be Associate Editors and to assist in the new course of this multidisciplinary journal, to encourage it to survive and to be the forum where to post the most important findings of our intriguing research of new and innovative metal-based drugs. With your help, the journal has an excellent potential to rapidly become the most important reference in the biomedical literature of drugs for diseases such as cancer and diabetes or for diagnostics based on the modern molecular approach formetals in biology and medicine. \u0000 \u0000Undoubtedly, of the many fields where metals can help medicine with innovative drugs, chemotherapy and particularly cancer chemotherapy is forever attracting considerable interest. In this context it is important to note that there is a decreasing interest in DNA-damaging drugs. Unlike the era initiated with the discovery of the anticancer activity of mechlorethamine in 1940s, it is more commonly accepted that the new golden era of cancer chemotherapy is driven by a new series of drugs characterized by their capacity to interact with targets expressed with high selectivity only by tumour cells and this is now giving rise to drugs that are actually available in clinical practice. It is clear that the “old drugs” will still accompany us in the clinical treatment of tumours for many years. It is similarly evident that the few improvements we may expect from these drugs (those acting on nucleic acids or on macromolecules of the mitotic spindle) are those associated with a better pharmacokinetic profile that can lead to the reduction of systemic toxicity, the main problem limiting the use of such drugs. \u0000 \u0000Researchers are now convinced that targets such as DNA, RNA, and tubulin do not provide sufficient selectivity for cancer cells without negative effects on healthy tissues. Also, factors such as the high tendency to develop resistance towards chemotherapeutic agents, the genetic instability of tumour cells, their heterogeneity, and their elevated mutation index are elements sufficient to circumvent the practical application of chemotherapy. Furthermore, we now have new ways to develop and research ideas on the processes of gene regulation involved in tumour malignancy: activation and repression of signal transduction pathways depending on various extracellular signals and/or cellmutations that select their capacity to survive, generate tumours, and to invade and give rise to metastases, the ultimate target of chemotherapy. \u0000 \u0000We therefore have important work to do: to obtain new metal-based drugs that are not related to cisplatin or platinum analogues currently in use or in the advanced stages of development, since these represent part of the old strategy of antitumour chemotherapy. We are conscious of the difficulties of the game but we will run this race with the important advantage","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"2007 ","pages":"16260"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2007/16260","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27363335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Toxic effects due to high aluminum body loads were observed in a number of conditions following ingestion of Al-containing antacids. Bio-availability of aluminum depends not only on the solubility of the ingested salt but also on the physico-chemical properties of the soluble Al complexes formed in body fluids. Amino acids may, upon interaction with Al-salts, form absorbable Al-complexes. Hence, complex formation equilibria between Al(3+) and either, L- histidine or L-tyrosine were studied by glass electrode potentiometric (0.1 mol/L LiCl ionic medium, 298 K), proton NMR and uv spectrophotometric measurements. Non linear least squares treatment of the potentiometric data indicates that in the concentration ranges: 0.5=C(A1)=2.0 ; 1.0=C(His)=10.0; 2.5=PH=6.5, in Al(3+) + His solutions, the following complexes (with log overall stability constants given in parenthesis) are formed: Al(HHis)(3+)(12.21+/-0.08); Al(His)(2+), (7.25+/-0.08); and Al(HHis)His(2+), (20.3+/-0.1). In Al(3+) + Tyr solutions in the concentration range 1.0=C(Tyr)=3.0 mmol/L and ligand to metal concentration ratio from 2:1 to 3:1, in the pH interval from 3.0 to 6.5 the formation of the following complexes was detected: Al(HTyr)(2+), (12.72+/-0.09); Al(Tyr)(2+), (10.16+/-0.03) and Al(OH)(2)Tyr , (2.70+/-0.05). Proton NMR data indicate that in Al(His)(2+) complex histidine acts as a monodentate ligand but its bidentate coordination is possible with carboxylate oxygen and imidazole 1-nitrogen as donors. In Al(HTyr)(3+) complex tyrosine is a monodentate ligand with carboxylate oxygen as donor. The mechanism of the formation of complexes in solution is discussed as well as their possible role in aluminum toxicity.
{"title":"Solution Equilibria between Aluminum(III) Ion and L-histidine or L-tyrosine.","authors":"Predrag Djurdjevic, Ratomir Jelic, Dragana Dzajevic, Mirjana Cvijovic","doi":"10.1155/MBD.2002.235","DOIUrl":"https://doi.org/10.1155/MBD.2002.235","url":null,"abstract":"<p><p>Toxic effects due to high aluminum body loads were observed in a number of conditions following ingestion of Al-containing antacids. Bio-availability of aluminum depends not only on the solubility of the ingested salt but also on the physico-chemical properties of the soluble Al complexes formed in body fluids. Amino acids may, upon interaction with Al-salts, form absorbable Al-complexes. Hence, complex formation equilibria between Al(3+) and either, L- histidine or L-tyrosine were studied by glass electrode potentiometric (0.1 mol/L LiCl ionic medium, 298 K), proton NMR and uv spectrophotometric measurements. Non linear least squares treatment of the potentiometric data indicates that in the concentration ranges: 0.5</=C(A1)</=2.0 ; 1.0</=C(His)</=10.0; 2.5</=PH</=6.5, in Al(3+) + His solutions, the following complexes (with log overall stability constants given in parenthesis) are formed: Al(HHis)(3+)(12.21+/-0.08); Al(His)(2+), (7.25+/-0.08); and Al(HHis)His(2+), (20.3+/-0.1). In Al(3+) + Tyr solutions in the concentration range 1.0</=C(Tyr)</=3.0 mmol/L and ligand to metal concentration ratio from 2:1 to 3:1, in the pH interval from 3.0 to 6.5 the formation of the following complexes was detected: Al(HTyr)(2+), (12.72+/-0.09); Al(Tyr)(2+), (10.16+/-0.03) and Al(OH)(2)Tyr , (2.70+/-0.05). Proton NMR data indicate that in Al(His)(2+) complex histidine acts as a monodentate ligand but its bidentate coordination is possible with carboxylate oxygen and imidazole 1-nitrogen as donors. In Al(HTyr)(3+) complex tyrosine is a monodentate ligand with carboxylate oxygen as donor. The mechanism of the formation of complexes in solution is discussed as well as their possible role in aluminum toxicity.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 5","pages":"235-48"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gordana Bogdanović, Vesna Kojić, Tatjana Srdić, Dimitar Jakimov, Milos I Djuran, Zivadin D Bugarcić, Mirjana Baltić, Vladimir V Baltić
The platinum (II)complexes, cis-[PtCl(2)(CH(3)SCH(2)CH(2)SCH(3))] (Pt1), cis-[PtCl(2)(dmso)(2)] (dmso is dimethylsulfoxide; Pt2) and cis-[PtCl(2)(NH(3))(2)] (cisplatin), and taxol (T) have been tested at different equimolar concentrations. Cells were exposed to complexes for 2 h and left to recover in fresh medium for 24, 48 or 72 h. Growth inhibition was measured by tetrazolium WST1 assay Analyses of the cell cycle, and apoptosis were performed by flow cytometry, at the same exposure times. The IC50 value of each platinum(II) complex as well as combination index (CI; platinum(II) complex + taxol) for various cytotoxicity levels were determined by median effects analysis.MCF7 cells were found to be sensitive to both Pt1 and Pt2 complexe These cisplatin analogues influenced the cell growth more effectively as compared to cisplatin. Cytotoxic effect was concentration and time-dependent. Profound growth inhibitory effect was observed for Pt1 complex, across all its concentrations at all recovery periods. A plateau effect was achieved three days after treatment at Pt1 concentrations = 1 muM. Pt2, however, decreased MCF7 cells survival only for the first 24 h ranging between 50-55%. Pt2 cytotoxicity sharply decreased thereafter, approaching 2 h - treatment cytotoxicity level. The median IC50 values for Pt1 and Pt2 were similar (0.337 and 0.3051 muM, respectively) but only for the first 24 h. The IC50 values for Pt1 strongly depend on the recovery period. On simultaneos exposure of cells to taxol and platinum(II) complexes no consistent effect was found. The Cls for combinations of taxol with Pt1 or Pt2 revealed cytotoxic effects that were in most Cases synergistic (Pt1) or less than addtiive (Pt2). Flow cytometry analysis has shown that each platinum(II) complex induced apoptosis in MCF7 cells. The level of apoptosis correlated with cytotoxicity level for the range concentrations. Both cisplatin analogues, at IC50 concentrations, increased the number of MCF7 cells in G0G1 phase of cell cycle. Pt2-treated cells remained arrested in G0G1 phase up to 72 h after treatment. Combination of Pt2 and taxol caused further arrest of cells in G0G1 phase (24 h) in parallel with strong decrement of G2M phase cells.
{"title":"Growth Effects of Some Platinum(II) Complexes with Sulfur-Containing Carrier Ligands on MCF7 Human Breast Cancer Cell Line upon Simultaneous Administration with Taxol.","authors":"Gordana Bogdanović, Vesna Kojić, Tatjana Srdić, Dimitar Jakimov, Milos I Djuran, Zivadin D Bugarcić, Mirjana Baltić, Vladimir V Baltić","doi":"10.1155/MBD.2002.33","DOIUrl":"https://doi.org/10.1155/MBD.2002.33","url":null,"abstract":"<p><p>The platinum (II)complexes, cis-[PtCl(2)(CH(3)SCH(2)CH(2)SCH(3))] (Pt1), cis-[PtCl(2)(dmso)(2)] (dmso is dimethylsulfoxide; Pt2) and cis-[PtCl(2)(NH(3))(2)] (cisplatin), and taxol (T) have been tested at different equimolar concentrations. Cells were exposed to complexes for 2 h and left to recover in fresh medium for 24, 48 or 72 h. Growth inhibition was measured by tetrazolium WST1 assay Analyses of the cell cycle, and apoptosis were performed by flow cytometry, at the same exposure times. The IC50 value of each platinum(II) complex as well as combination index (CI; platinum(II) complex + taxol) for various cytotoxicity levels were determined by median effects analysis.MCF7 cells were found to be sensitive to both Pt1 and Pt2 complexe These cisplatin analogues influenced the cell growth more effectively as compared to cisplatin. Cytotoxic effect was concentration and time-dependent. Profound growth inhibitory effect was observed for Pt1 complex, across all its concentrations at all recovery periods. A plateau effect was achieved three days after treatment at Pt1 concentrations </= 1 muM. Pt2, however, decreased MCF7 cells survival only for the first 24 h ranging between 50-55%. Pt2 cytotoxicity sharply decreased thereafter, approaching 2 h - treatment cytotoxicity level. The median IC50 values for Pt1 and Pt2 were similar (0.337 and 0.3051 muM, respectively) but only for the first 24 h. The IC50 values for Pt1 strongly depend on the recovery period. On simultaneos exposure of cells to taxol and platinum(II) complexes no consistent effect was found. The Cls for combinations of taxol with Pt1 or Pt2 revealed cytotoxic effects that were in most Cases synergistic (Pt1) or less than addtiive (Pt2). Flow cytometry analysis has shown that each platinum(II) complex induced apoptosis in MCF7 cells. The level of apoptosis correlated with cytotoxicity level for the range concentrations. Both cisplatin analogues, at IC50 concentrations, increased the number of MCF7 cells in G0G1 phase of cell cycle. Pt2-treated cells remained arrested in G0G1 phase up to 72 h after treatment. Combination of Pt2 and taxol caused further arrest of cells in G0G1 phase (24 h) in parallel with strong decrement of G2M phase cells.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"9 1-2","pages":"33-43"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.33","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The antibacterial and antifungal activity of zinc(II) carboxylates with composition Zn(RCOO)(2)*nH(2)O(R =H-, CH(3) (-), CH(3)CH(2)CH(2) (-), (CH(3))(2)CH-, XCH(2) (-), X=Cl, Br, I, n=0 or 2), [ZnX(2)(Nia(+)CH(2)COO(-))(2)](Nia=nicotinamide, X=Cl, Br, I) and [Zn(XCH(2)COO)(2)(Caf)(2)]*2H(2)O (Car=caffeine, X=Cl, Br) is studied against bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans. The structural types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii) substitution of hydrogen atom of carboxylate by halogen and (iii) presence of N-donor organic ligands on the biological activity is discussed.
{"title":"Antibacterial and Antifungal Activity of Zinc(II) Carboxylates With/Without N-Donor Organic Ligands.","authors":"V Zelenák, K Györyová, D Mlynarcík","doi":"10.1155/MBD.2002.269","DOIUrl":"https://doi.org/10.1155/MBD.2002.269","url":null,"abstract":"<p><p>The antibacterial and antifungal activity of zinc(II) carboxylates with composition Zn(RCOO)(2)*nH(2)O(R =H-, CH(3) (-), CH(3)CH(2)CH(2) (-), (CH(3))(2)CH-, XCH(2) (-), X=Cl, Br, I, n=0 or 2), [ZnX(2)(Nia(+)CH(2)COO(-))(2)](Nia=nicotinamide, X=Cl, Br, I) and [Zn(XCH(2)COO)(2)(Caf)(2)]*2H(2)O (Car=caffeine, X=Cl, Br) is studied against bacterial strains Staphylococcus aureus, Escherichia coli and yeast Candida albicans. The structural types are assigned to the prepared compounds and the influence of (i) carboxylate chain length, (ii) substitution of hydrogen atom of carboxylate by halogen and (iii) presence of N-donor organic ligands on the biological activity is discussed.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 5","pages":"269-74"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.269","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Brine shrimp lethality of a new series of 16 to 26-membered macrocycles of iron(II) containing tetraaza groups and prepared by the template condensation reaction of diacarboxylic acids (malonic, succinic, glutaric or adipic) with 2,6-diaminopyridine and diethylenetriamine in 1:2:2 molar ratios have been studied. Structures and bonding of the macrocyclic complexes have been proposed based on elemental analyses, IR, electronic, X-ray and mass spectral studies. An octahedral geometry for these complexes has been proposed as the binding sites are the nitrogen atoms of the macrocycles. The formation of the complexes as [Fe(L(n))Cl(2)] has been established on the basis of the chemical composition. The complexes have also been screened against several microbes.
{"title":"Txicological Aspects of Newly Designed Macrocyclic Complexes of Iron(II).","authors":"Ashu Chaudhary, R V Singh","doi":"10.1155/MBD.2002.315","DOIUrl":"https://doi.org/10.1155/MBD.2002.315","url":null,"abstract":"<p><p>Brine shrimp lethality of a new series of 16 to 26-membered macrocycles of iron(II) containing tetraaza groups and prepared by the template condensation reaction of diacarboxylic acids (malonic, succinic, glutaric or adipic) with 2,6-diaminopyridine and diethylenetriamine in 1:2:2 molar ratios have been studied. Structures and bonding of the macrocyclic complexes have been proposed based on elemental analyses, IR, electronic, X-ray and mass spectral studies. An octahedral geometry for these complexes has been proposed as the binding sites are the nitrogen atoms of the macrocycles. The formation of the complexes as [Fe(L(n))Cl(2)] has been established on the basis of the chemical composition. The complexes have also been screened against several microbes.</p>","PeriodicalId":18452,"journal":{"name":"Metal-Based Drugs","volume":"8 6","pages":"315-21"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/MBD.2002.315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27437899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}